Showing results (651-660 of 673) with videos related to
Sort By:
Pageof 68
Blood|January 10, 2022
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemiaJohn Mascarenhas, Heidi E Kosiorek, Josef T Prchal, et al.Leukemia|March 13, 2025
Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia veraYan Beauverd, Jean-Christophe Ianotto, Kyaw Htin Thaw, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNsRobyn M Emanuel, Amylou C Dueck, Holly L Geyer, et al.Blood Advances|July 8, 2022
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needsMarta Sobas, Jean-Jacques Kiladjian, Yan Beauverd, et al.JAMA|December 6, 2019
Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical TrialRahul Bhatnagar, Hania E G Piotrowska, Magda Laskawiec-Szkonter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled DiseaseHolly Geyer, Robyn Scherber, Heidi Kosiorek, et al.Blood|March 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMTNicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, et al.Leukemia Research|November 3, 2017
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needsAllison H Scotch, Heidi Kosiorek, Robyn Scherber, et al.Haematologica|August 20, 2016
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working GroupHolly L Geyer, Heidi Kosiorek, Amylou C Dueck, et al.The New England Journal of Medicine|December 12, 2013
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2J Nangalia, C E Massie, E J Baxter, et al.Pageof 68